Unleashing the Power of Digital Pathology & AI to Accelerate Drug Development Across All Therapeutic Areas
Time: 2:00 pm
day: Day One
Details:
- How can biopharma leverage AI and digital pathology to drive improvements along the continuum of drug R&D (target selection, MoA, PD, Endpoint analysis, Combination Strategies, Selection and Stratification)?
- What role do foundation models play in accelerating AI models development and expanding diagnostic capabilities?
- Highlighting the potential of AI and digital pathology in non-oncology areas